A research about the new therapy for glaucomatous optic nerve damage based on the endogenous neuroprotective system
| Project/Area Number |
14370561
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Ophthalmology
|
|---|
| Research Institution | Kumamoto University |
|---|
Principal Investigator |
TANIHARA Hidenobu Kumamoto University, Graduate School of Medical Sciences, Ophthalmogy and visual science, Professor, 大学院・医学薬学研究部, 教授 (60217148)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
FUKUSHIMA Mikiko Kumamoto University, Kumamoto University Hospital, Ophthalmogy, Assistant, 医学部附属病院, 助手 (10284770)
HIRATA Akira Kumamoto University, Kumamoto University Hospital, Ophthalmogy, Instructor, 医学部附属病院, 講師 (60295144)
木村 章 熊本大学, 医学部附属病院, 講師 (20284771)
|
|---|
| Project Period (FY) |
2002 – 2003
|
| Project Status |
Completed (Fiscal Year 2003)
|
| Budget Amount *help |
¥14,900,000 (Direct Cost: ¥14,900,000)
Fiscal Year 2003: ¥5,500,000 (Direct Cost: ¥5,500,000)
Fiscal Year 2002: ¥9,400,000 (Direct Cost: ¥9,400,000)
|
|---|
| Keywords | glaucoma / neuroprotection / cytokine / statin / antithrombin III / familial amyloid polyneuropathy / endogenous survival factor / SEREX法 |
|---|
| Research Abstract |
In this research, we investigated our hypothesis that immune reaction and stress response exerted neuroprotective effect on glaucomatous optic nerve damage. First, we reported that IL-6, multifunctional cytokine produced by several cells, provided a neuroproctive effect on retinal damage (BBRC 302:226,2003). Second, we demonstrated the neuroprotective effect of statin (Arch Ophthalmol 120:1707,2002) and antithrombin III (IOVS 44:332,2003) and the beneficial effects of anti-LOX-1 antibody on the endotoxin-induced inflammation (Pro Natl Acad Sci USA 100:1274,2003) by inhibiting leukocyte-endothelial interaction. Third, we demonstrated the neuroprotective effect of LEDGF, enodogenous and exogenous survival factor, on retinal damage (Brain Res 991:163,2003). Fourth, we elucidated the clinical and surgical outcomes of the treatment of unique type of secondary glaucoma associated with transthyretin related familial amyliod polyneuropathy (Arch Ophthalmol 121:351,2003).
|
Report
(3 results)
Research Products
(19 results)
